Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 12/8/2009
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||0138U / 1||UN / IM|
Administered by: Unknown Purchased by: Unknown
Symptoms: Abdominal pain, Diarrhoea, Vaccination complication, Vomiting, Activities of daily living impaired
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? No
Other Medications: Unknown
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES0804AUS00139
Write-up:Information was obtained on request by the Company from the agency via a Public Case Detail Form and a Case Line Listing concerning a 16 year old female who on 24-APR-2007 was vaccinated with her second dose of GARDASIL (Lot No. 655742/0138U, Batch No. J0800, Expiry date 07-AUG-2009). On 24-APR-2007, after vaccination, the patient experienced abdominal pain, diarrhoea and vomiting. The patient was unable to attend school. It was reported that the patient was previously a healthy year 11 student. The patient''s general physician now considered symptoms may be vaccine associated and has advised to have the third dose following exams in November 2007. At the time of reporting to the agency on 13-SEP-2007, the patient had recovered from abdominal pain, diarrhoea and vomiting. The agency considered that abdominal pain, diarrhoea and vomiting were certainly related to therapy with GARDASIL. The original reporting source was not provided. Abdominal pain, diarrhoea and vomiting were considered to be disabling by the agency. Subsequently the patient''s experience was reported in an article. Additional information is not expected.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166